Branched Stent Grafts Market Regional Analysis

Global Branched Stent Grafts Market size was valued at USD 324.39 Million in 2023 and is poised to grow from USD 349.37 Million in 2024 to USD 632.42 Million by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032). 

The branched stent grafts market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Medtronic plc ', 'Cook Medical ', 'W. L. Gore & Associates, Inc. ', 'Endologix, Inc. ', 'JOTEC GmbH ', 'LeMaitre Vascular, Inc. ', 'MicroPort Scientific Corporation ', 'Terumo Corporation ', 'Vascutek, Ltd. ', 'Zenith (Cook Medical) ', 'TriVascular Technologies, Inc. ', 'Bolton Medical ', 'Lombard Medical, Inc. ', 'QualiMed Innovative Medizinprodukte GmbH ', 'Nano Endoluminal, S.L. '

The rise in the number of endovascular aneurysm repair (EVAR) procedures, improvements in patient care quality, and advancements in medical technology are a few of the major factors that are influencing the branched stent grafts market. Furthermore, an ageing population and a high prevalence of AAA (abdominal aortic aneurysm) are driving growth in the branched stent grafts market.

Abdominal endovascular aneurysm repair (AEVAR), branched endovascular aneurysm repair (BEVAR), and thoracic endovascular aneurysm repair (TEVAR) have all become standard treatments for aneurysms. The majority of people choose these procedures because they are safe, effective, less expensive, and reduce operative time. The success of these procedures is heavily reliant on the use of image guidance techniques such as X-rays.

North America has a largest revenue share. This is because the region has a well-developed healthcare infrastructure, key players, and reimbursement coverage. Furthermore, due to the strong presence of major market players, the regional market is highly competitive. Asia Pacific, on the other hand, is expected to be the fastest-growing regional market, with a CAGR of more over the forecast period.